AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025
Dec 30, 2025
31542_dirs_2025-12-30_217c5428-c75d-4395-8288-24131cc6ca5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-12-29
Reporting Person: Elsbernd Brian (Chief Compliance/Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-29 | Common Stock, par value $0.001 per share | M | 6667 | — | Acquired | 245124 | Direct |
| 2025-12-29 | Common Stock, par value $0.001 per share | F | 2623 | — | Disposed | 242501 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | Restricted Stock Units | $ | M | 6667 | Disposed | Common Stock (6667) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
F3: Derivative securities vested in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024, and 1/3rd on December 27, 2025.
F4: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 29, 2025.